Review
Open access
Sep 2026
Catechins in stroke: multi-target mechanisms, preclinical evidence, and translational challenges
Catechins represent promising candidate drugs for stroke due to their multiple neuroprotective potentials, but most preclinical evidence arises from pretreatment paradigms, which are confounded by heterogeneity in dosage, age, and experimental models.
Yue Zhang, Shuang-Cui Wang, Qing-Qiang Yuan
· Frontiers in Pharmacology · 0 citations